Amplitude Ventures closes $263 million for second precision medicine VC fund
Amplitude has already made four investments from Fund II.
Amplitude has already made four investments from Fund II.
Down rounds rose from seven percent in 2022 to 31 percent last year.
Two dozen third-party science and research organizations are being backed by the new Strategic Science Fund.
Projects from Swift Medical, RxPx, Gotcare, and AlayaCare carry a collective $26-million value.
Plus: CloudMD to go private after acquisition spree dries liquidity.
“Federally procured and provincially distributed” healthcare alienates practitioners from process.
Bronwyn Bridges discusses her journey into healthtech with PragmaClin and her entrepreneurial “superpower.”
Pre-seed, seed-stage VC funding declines as late-stage investment continues descent.
Plus: Oracle’s $28-billion Cerner healthtech acquisition is losing clients.
CloudMD had been reviewing options to solve its liquidity issues as a result of its numerous acquisitions.
Plus: Ottawa firm acquires mental health platform for first responders.
Leaders from Cohere, MedEssist, Transformer Lab, and Socratica shared their stories at BetaKit Town Hall.
R&D-stage startup is using AI and quantum chemistry to purify the world’s most precious resource.
Rob Atkinson pines for a “killer instinct” while launching the CCIC.
Plus: Drug discovery startup from controversial ex-Stanford president raises $1B.